IL-4/IL-4Rα signaling activates PPARγ to promote oligodendrocyte differentiation and remyelination
Study Overview This research delves into the role of interleukin-4 (IL-4) and its receptor (IL-4Rα) in promoting the differentiation of […]
CAR T cell therapy: Autoimmune neurological uses and neurotoxicities
Applications of Car T Cell Therapy in Autoimmune Neurology Chimeric Antigen Receptor (CAR) T cell therapy has emerged as a
CAR T cell therapy: Autoimmune neurological uses and neurotoxicities Read Post »
Sex differences for clinical presentations and co-pathologies in four-repeat tauopathies
Clinical Presentations Clinical presentations of four-repeat tauopathies, such as frontotemporal dementia (FTD) and progressive supranuclear palsy (PSP), exhibit a range
Sex differences for clinical presentations and co-pathologies in four-repeat tauopathies Read Post »
From Diagnosis to Recovery: Charting the Path of Children With Chronic Inflammatory Demyelinating Polyneuropathy in a Tertiary Care Setting
Multidisciplinary Approach to Diagnosis In the diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP) in pediatric patients, a comprehensive and multidisciplinary
Use of Therapeutic Plasma Exchange in Autoimmune Neuromuscular Disorders
Therapeutic Plasma Exchange Mechanism Therapeutic Plasma Exchange (TPE) is a clinical procedure that involves the removal of plasma from a
Use of Therapeutic Plasma Exchange in Autoimmune Neuromuscular Disorders Read Post »
From Diagnosis to Recovery: Charting the Path of Children With Chronic Inflammatory Demyelinating Polyneuropathy in a Tertiary Care Setting
Patient Journey The journey of a child diagnosed with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) often begins with a series of
From Diagnosis to Recovery: Charting the Path of Children With Chronic Inflammatory Demyelinating Polyneuropathy in a Tertiary Care Setting
Patient Population Characteristics The study of children diagnosed with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in a tertiary care setting reveals
Vitreous Opacities and Polyneuropathy in a 38-Year-Old Woman
Case Description A 38-year-old woman presented with a complex medical history, specifically complaints of visual disturbances and progressive numbness in
Vitreous Opacities and Polyneuropathy in a 38-Year-Old Woman Read Post »
Treatment of Multiple Sclerosis
Treatment Approaches Multiple sclerosis (MS) management involves a multifaceted approach that integrates pharmacological interventions, lifestyle modifications, and supportive therapies to
Treatment of Multiple Sclerosis Read Post »
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
Disease Mechanism The disease mechanism underlying Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) involves an autoimmune response that disrupts the normal
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease Read Post »